EUVIMEDEUVIMED entdecken
Open Access

Leptin potentiates bone loss at skeletal sites distant from focal inflammation in female ob/ob mice

Russell T Turner iD, Kenneth A Philbrick, Carmen P Wong, Aidan R Fichter, Adam J Branscum, Urszula T Iwaniec iD

Journal of Endocrinology · 2025

DOI: 10.1530/joe-24-0324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2025. Verfasst von Russell T Turner und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Leptin, Inflammation, Bone Resorption. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptin increases focal inflammation and osteolysis induced by polyethylene particles in leptin-deficient ob/ob mice, suggesting that this adipokine, an important immune modulator, contributes to orthopedic implant failure. Focal inflammation leads to bone loss at distant skeletal sites, and it is plausible that leptin also contributes to this response. We tested this possibility in 6-week-old female ob/ob mice (6–8/group) by evaluating bone architecture, turnover and gene expression 12 days following the surgical placement of polyethylene particles over the calvaria. Particle treatment had minimal effect on bone mass, density or cancellous bone architecture in the femur and 5th lumbar vertebra (LV). However, compared to controls, particle treatment altered tibial expression levels of 32/84 genes related to bone metabolism. Subcutaneous infusion of leptin (6 μg/d) to mice following the placement of polyethylene particles over the calvaria (combination treatment) resulted in cancellous bone loss in the distal femur metaphysis and LV and in the differential expression of 34/84 genes, 15 of which overlapped with particle treatment. Notably, combination treatment, but not particle treatment, resulted in increased expression of genes strongly associated with bone turnover and response to inflammation. Leptin treatment alone (0.1–10 μg/day) did not result in bone loss in the femur or LV in the ob/ob mice. These findings suggest that leptin exaggerates the detrimental effects of particle-induced inflammation on bone turnover balance, leading to systemic bone loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinInflammationBone ResorptionAnimalsFemaleMiceMice, ObeseBone DensityFemurPolyethyleneLumbar VertebraeBone RemodelingSkullMice, Inbred C57BL

Stichwörter der Autor:innen

bone losshistomorphometryinflammationleptinmicrocomputed tomographyosteolysis

Substanzen

LeptinPolyethylene

Autor:innen und Institutionen

ORCID-Profile: Russell T Turner, Urszula T Iwaniec

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Turner, R. T., Philbrick, K. A., Wong, C. P., Fichter, A. R., Branscum, A. J., & Iwaniec, U. T. (2025). Leptin potentiates bone loss at skeletal sites distant from focal inflammation in female ob/ob mice. Journal of Endocrinology. https://doi.org/10.1530/joe-24-0324

Vancouver

Turner RT, Philbrick KA, Wong CP, Fichter AR, Branscum AJ, Iwaniec UT. Leptin potentiates bone loss at skeletal sites distant from focal inflammation in female ob/ob mice. Journal of Endocrinology. 2025. doi:10.1530/joe-24-0324

BibTeX
@article{Turner2025,
  author = {Turner, Russell T and Philbrick, Kenneth A and Wong, Carmen P and Fichter, Aidan R and Branscum, Adam J and Iwaniec, Urszula T},
  title = {Leptin potentiates bone loss at skeletal sites distant from focal inflammation in female ob/ob mice},
  journal = {Journal of Endocrinology},
  year = {2025},
  doi = {10.1530/joe-24-0324}
}
Kostenlos starten →